Medtronic
MDT
2,148 hedge funds and large institutions have $94.6B invested in Medtronic in 2025 Q2 according to their latest regulatory filings, with 144 funds opening new positions, 887 increasing their positions, 878 reducing their positions, and 148 closing their positions.
19% more call options, than puts
Call options by funds: $1.02B | Put options by funds: $860M
11% more capital inflows, than outflows
Capital inflows: $5.45B | Capital outflows: $4.9B
1% more repeat investments, than reductions
Existing positions increased: 887 | Existing positions reduced: 878
0.45% more ownership
Funds ownership: 84.12% → 84.57% (+0.45%)
3% less first-time investments, than exits
New positions opened: 144 | Existing positions closed: 148
2% less funds holding
Funds holding: 2,181 → 2,148 (-33)
27% less funds holding in top 10
Funds holding in top 10: 44 → 32 (-12)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$917M |
| 2 |
BlackRock
New York
|
+$432M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$302M |
| 4 |
Millennium Management
New York
|
+$262M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$165M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Longview Partners
St Peter Port,
Guernsey
|
-$467M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
-$442M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$340M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$229M |
| 5 |
JP Morgan Chase
New York
|
-$217M |
MDT Hedge Fund Activity: Q2 2025 in Review
2,148 of the 7,627 institutional investors tracked by Wall St. Rank reported a position in Medtronic (MDT) for Q2 2025, worth a combined $94.6B — down 2.4% from $96.9B a quarter earlier.
Sellers outnumbered buyers: 148 funds closed out of MDT and 144 opened new positions — a net loss of 4 holders — while 878 trimmed existing stakes and 887 added.
The largest buyer was Goldman Sachs, adding an estimated $917M. The largest seller was Longview Partners, exiting entirely with an estimated $467M sold.
- 2,148 institutional investors held Medtronic (MDT) as of Q2 2025, down from 2,181 in Q1 2025.
- Funds reported $94.6B of Medtronic stock for Q2 2025, down 2.4% quarter-over-quarter.
- 144 funds opened new Medtronic positions in Q2 2025 and 148 closed out, a net change of -4 holders.
- The largest Medtronic buyer in Q2 2025 was Goldman Sachs, an estimated $917M added.
- The largest Medtronic seller in Q2 2025 was Longview Partners, an estimated $467M sold.
Based on aggregated 13F filings for Q2 2025.